Clinical outcome and immune reconstitution following alemtuzumab T cell depleted nonmyeloablative allogeneic immunotherapy using HLA mis-matched (3-5/6) related hematopoietic stem cells.

Published

Conference Paper

Full Text

Link to Item

Duke Authors

Cited Authors

Rizzieri, DA; Koh, LP; Long, GD; Gasparetto, C; Vredenburgh, JJ; Buckley, PJ; Gong, G; Lagoo, A; Davis, P; Lassiter, M; Rooney, B; Niedzwiecki, D; Waters-Pick, B; Burleson, J; Thompson, M; Johns, A; Folz, RJ; Horwtiz, ME; Sullivan, K; Morris, A; Chao, NJ

Published Date

November 16, 2003

Published In

Blood

Volume / Issue

102 / 11

Start / End Page

482A - 482A

Published By

AMER SOC HEMATOLOGY

Pages

1

International Standard Serial Number (ISSN)

0006-4971

Conference Name

45th Annual Meeting of the American-Society-of-Hematology

Conference Location

SAN DIEGO, CALIFORNIA

Conference Start Date

December 6, 2003

Conference End Date

December 9, 2003